TABLE-Stella Pharma -2025/26 parent results

May 13 (Reuters)- Stella Pharma Corporation PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Mar 31, 2026 Mar 31, 2025 Mar 31, 2027 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST Sales 323 mln 961 mln 1.04 (-66.4 pct) (+256.6 pct) (+221.0 pct) Operating loss 748 mln loss 90 mln loss 696 mln Recurring loss 778 mln loss 137 mln loss 625 mln Net loss 780 mln loss 140 mln loss 628 mln EPS loss 22.95 yen loss 4.22 yen loss 17.11 yen Ann Div NIL NIL NIL -Q2 Div NIL NIL NIL -Q4 Div NIL NIL NIL NOTE - Stella Pharma Corporation. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T